CVS HEALTH CORP
CVSNYSE🏆 #131 by market capEarnings Oct 27 · PreUS Equity
$86.55▼ $1.28 (−1.48%)
LiveTrack CVS
Get earnings, price moves & breaking news on Telegram
24h▼ 1.5%
7d▼ 0.6%
14d▼ 8.4%
30d▼ 7.0%
ytd▲ 9.1%
1y▲ 14.5%
🏦Market Cap
$110.43B
Mid Cap
📈Revenue Growth (YoY)
+7.8%
Slowing
📊Gross Margin
14.2%
Thin
💵FCF Margin
2.8%
Thin
⚖️P/S Ratio
0.3x
Cheap
Otter Score
64
Fair
CVS HEALTH CORP
CVSAnalyst Ratings
Price
$86.55
Total
41
Raised
6
Lowered
3
Avg PT
$111.20
H / L
$123 / $92
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
UBS | Reiterated | Buy | 2026-09-03 | $118.00 | +36.30% |
Argus Research | Reiterated | Buy | 2026-08-19 | $114.00 | +31.70% |
JP Morgan | Reiterated | Overweight | 2026-08-12 | $86.00 | −0.60% |
Evercore ISI Group | Reiterated | Outperform | 2026-08-06 | — | — |
Barclays | Reiterated | Overweight | 2026-08-06 | $108.00 | +24.80% |
Truist Securities | Reiterated | Buy | 2026-07-14 | — | — |
Wells Fargo | Reiterated | Overweight | 2026-07-13 | $123.00 | +42.10% |
RBC Capital | Reiterated | Outperform | 2026-07-09 | $113.00 | +30.60% |
Cantor Fitzgerald | Reiterated | Overweight | 2026-07-07 | $110.00 | +27.10% |
B of A Securities | Reiterated | Buy | 2026-06-23 | — | — |
Mizuho | Reiterated | Outperform | 2026-06-08 | — | — |
Morgan Stanley | Reiterated | Overweight | 2026-06-04 | $111.00 | +28.20% |
Bernstein | Reiterated | Outperform | 2026-05-13 | $112.00 | +29.40% |
TD Cowen | Reiterated | Buy | 2026-05-11 | — | — |
Baird | Reiterated | Outperform | 2026-04-15 | — | — |
Piper Sandler | Reiterated | Overweight | 2026-03-31 | $112.00 | +29.40% |
Jefferies | Reiterated | Buy | 2025-06-30 | $120.00 | +38.60% |
Leerink Partners | Upgraded | Market Perform → Outperform | 2025-02-13 | $98.00 | +13.20% |
Deutsche Bank | Upgraded | Hold → Buy | 2024-12-03 | $92.00 | +6.30% |
Goldman Sachs | Reiterated | Buy | 2024-05-02 | $91.00 | +5.10% |
Wolfe Research | Upgraded | Peer Perform → Outperform | 2023-09-12 | $80.00 | −7.60% |
Edward Jones | Downgraded | Buy → Hold | 2023-08-18 | — | — |
Raymond James | Reiterated | Outperform | 2023-08-04 | — | — |
Credit Suisse | Reiterated | Outperform | 2023-05-08 | $117.00 | +35.20% |
Tigress Financial | Reiterated | Buy | 2021-12-23 | $125.00 | +44.40% |
BMO Capital | Reiterated | Market Perform | 2021-05-19 | $112.00 | +29.40% |
Guggenheim | Downgraded | Buy → Neutral | 2021-03-17 | — | — |
SVB Leerink | Reiterated | Market Perform | 2020-12-14 | — | — |
Citigroup | Reiterated | Buy | 2020-05-07 | — | — |
SunTrust Robinson Humphrey | Reiterated | Buy | 2020-04-13 | — | — |
CFRA | Reiterated | Strong Buy | 2020-02-13 | — | — |
Citi | Reiterated | Buy | 2019-11-07 | — | — |
Bank of America | Reiterated | Buy | 2019-09-12 | — | — |
Oppenheimer | Downgraded | Outperform → Perform | 2019-04-15 | — | — |
Leerink Swann | Reiterated | Outperform | 2018-02-09 | — | — |
Needham | Upgraded | Hold → Buy | 2017-11-10 | — | — |
Loop Capital | Reiterated | Hold | 2017-11-07 | — | — |
Cowen & Co. | Reiterated | Outperform | 2015-06-10 | $114.00 | +31.70% |
FBR Capital | Reiterated | Outperform | 2014-11-05 | — | — |
ISI Group | Upgraded | Buy → Strong Buy | 2014-01-22 | — | — |
Macquarie | Upgraded | Neutral → Outperform | 2012-12-14 | — | — |
Institution
UBS
Reiterated · Buy · 2026-09-03
$118.00
+36.30%
Argus Research
Reiterated · Buy · 2026-08-19
$114.00
+31.70%
JP Morgan
Reiterated · Overweight · 2026-08-12
$86.00
−0.60%
Evercore ISI Group
Reiterated · Outperform · 2026-08-06
—
—
Barclays
Reiterated · Overweight · 2026-08-06
$108.00
+24.80%
Truist Securities
Reiterated · Buy · 2026-07-14
—
—
Wells Fargo
Reiterated · Overweight · 2026-07-13
$123.00
+42.10%
RBC Capital
Reiterated · Outperform · 2026-07-09
$113.00
+30.60%
Cantor Fitzgerald
Reiterated · Overweight · 2026-07-07
$110.00
+27.10%
B of A Securities
Reiterated · Buy · 2026-06-23
—
—
Mizuho
Reiterated · Outperform · 2026-06-08
—
—
Morgan Stanley
Reiterated · Overweight · 2026-06-04
$111.00
+28.20%
Bernstein
Reiterated · Outperform · 2026-05-13
$112.00
+29.40%
TD Cowen
Reiterated · Buy · 2026-05-11
—
—
Baird
Reiterated · Outperform · 2026-04-15
—
—
Piper Sandler
Reiterated · Overweight · 2026-03-31
$112.00
+29.40%
Jefferies
Reiterated · Buy · 2025-06-30
$120.00
+38.60%
Leerink Partners
Upgraded · Market Perform → Outperform · 2025-02-13
$98.00
+13.20%
Deutsche Bank
Upgraded · Hold → Buy · 2024-12-03
$92.00
+6.30%
Goldman Sachs
Reiterated · Buy · 2024-05-02
$91.00
+5.10%
Wolfe Research
Upgraded · Peer Perform → Outperform · 2023-09-12
$80.00
−7.60%
Edward Jones
Downgraded · Buy → Hold · 2023-08-18
—
—
Raymond James
Reiterated · Outperform · 2023-08-04
—
—
Credit Suisse
Reiterated · Outperform · 2023-05-08
$117.00
+35.20%
Tigress Financial
Reiterated · Buy · 2021-12-23
$125.00
+44.40%
BMO Capital
Reiterated · Market Perform · 2021-05-19
$112.00
+29.40%
Guggenheim
Downgraded · Buy → Neutral · 2021-03-17
—
—
SVB Leerink
Reiterated · Market Perform · 2020-12-14
—
—
Citigroup
Reiterated · Buy · 2020-05-07
—
—
SunTrust Robinson Humphrey
Reiterated · Buy · 2020-04-13
—
—
CFRA
Reiterated · Strong Buy · 2020-02-13
—
—
Citi
Reiterated · Buy · 2019-11-07
—
—
Bank of America
Reiterated · Buy · 2019-09-12
—
—
Oppenheimer
Downgraded · Outperform → Perform · 2019-04-15
—
—
Leerink Swann
Reiterated · Outperform · 2018-02-09
—
—
Needham
Upgraded · Hold → Buy · 2017-11-10
—
—
Loop Capital
Reiterated · Hold · 2017-11-07
—
—
Cowen & Co.
Reiterated · Outperform · 2015-06-10
$114.00
+31.70%
FBR Capital
Reiterated · Outperform · 2014-11-05
—
—
ISI Group
Upgraded · Buy → Strong Buy · 2014-01-22
—
—
Macquarie
Upgraded · Neutral → Outperform · 2012-12-14
—
—
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space